Association of the involvement of axillary lymph nodes in HER‐2/neu overexpression in patients with breast cancer-Reference-Cited by-同舟云学术

Association of the involvement of axillary lymph nodes in HER‐2/neu overexpression in patients with breast cancer

Published:2019-04-11 Issue:3 Volume:25 Page:537-538
ISSN:1075-122X
Container-title:The Breast Journal
language:en
Short-container-title:Breast J

Author:

Ziaeemehr Aghigh¹²^ORCID,Shahidsales Soodabeh¹,Ghosi Zina²,Avan Amir³,Aldavood Amir S.²,Anvari Kazem²,Makhdoomi Yasha⁴,Asadi Mehdi²

Affiliation:

1. Cancer Research Center Mashhad University of Medical Sciences Mashhad Iran

2. Surgical Oncology Research Center Mashhad University of Medical Sciences Mashhad Iran

3. Metabolic Syndrome Research Center Mashhad University of Medical Sciences Mashhad Iran

4. Reza Oncology Center Mashhad Islamic Republic of Iran

Publisher

Hindawi Limited

Subject

Oncology,Surgery,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tbj.13282

Reference9 articles.

1. Five common cancers in Iran;Kolahdoozan S;Arch Iran Med,2010

2. The Distinctive Nature of HER2-Positive Breast Cancers

3. Immunohistochemical detection ofHER2/neu in patients with axillary lymph node negative breast carcinoma. A study of epidemiologic risk factors, histologic features, and prognosis

4. The significance of oncogene amplification in primary breast cancer

5. Comparison of ER, PR and HER‐2/neu reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer;Azizun‐Nisa BY;Asian Pac J Cancer Prev,2008

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autophagy and Breast Cancer: Connected in Growth, Progression, and Therapy;Cells;2023-04-14

2. Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer;Cancer Chemotherapy and Pharmacology;2020-10-17

3. Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer;Cell Death & Disease;2020-01